Macrophages are key to inflammation, a process that is the first line of defense against pathogens. Macrophages come in two types, M1 and M2. M1 macrophages largely focus on initiating and maintaining inflammation. M2 macrophages come in later in the inflammation process. A nuclear receptor called Nr4a2 is known to be involved in inflammation, but its mechanism of action is not known. In this Paper of the Week, a team led by Sahil Mahajan, Pawan Gupta, and colleagues at the Council of Scientific and Industrial Research in India demonstrated that Nr4a2 is a transcription factor that prompts macrophages to take on M2 characteristics. The investigators showed when ligands bound to Toll-like receptors on macrophages, the PI3K/Akt signaling pathway was triggered to eventually induce the expression of Nr4a2. In animal studies, the investigators showed that Nr4a2 was needed for survival against sepsis. The authors say, "Therapeutic intervention of Nr4a2 may provide a cure for inflammatory diseases." DOI 10.1074/jbc.P115.638064 18315 Schematic representation highlighting the role of Nr4a2 in macrophages.
